会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Method for selecting and producing vaccine components and vaccines based thereon
    • 基于此选择和制备疫苗组分和疫苗的方法
    • US20070082003A1
    • 2007-04-12
    • US10556733
    • 2004-05-17
    • Cornelis LeenhoutsRonald de GrootPeter Hermans
    • Cornelis LeenhoutsRonald de GrootPeter Hermans
    • A61K39/40A61K39/02G06F19/00C07K16/12
    • A61K39/092A61K2039/505C07K16/1275G01N33/56911Y02A50/47
    • The invention relates to the field of biology, more specifically to the field of immunology and microbiology. The invention further relates to the field of vaccines against microbial infections and especially bacterial vaccines, in particular to pneumococcal vaccines. More in particular, the invention relates to means and methods to identify, select and isolate a vaccine component for passive and/or active immunisation against a microorganism that can be killed by opsonophagocytic cells. The invention relates to a method to identify an opsonophagocytosis inducing antigen as a vaccine component for immunisation against a microorganism. The invention describes three pneumococcal proteins SlrA, IgAl proteinase, and PsaA, and their use as a vaccine component with or without PpmA. The invention also discloses the use of antibodies against said proteins for passive immunization and diagnosis.
    • 本发明涉及生物学领域,更具体涉及免疫学和微生物学领域。 本发明还涉及针对微生物感染的疫苗领域,特别是细菌疫苗领域,特别是肺炎球菌疫苗领域。 更具体地,本发明涉及鉴定,选择和分离针对可被调理吞噬细胞杀死的微生物的被动和/或主动免疫的疫苗组分的方法和方法。 本发明涉及一种鉴定诱导免疫细胞因子的抗原作为免疫微生物的疫苗组分的方法。 本发明描述了三种肺炎球菌蛋白SlrA,IgA1蛋白酶和PsaA,以及它们作为具有或不具有PpmA的疫苗组分的用途。 本发明还公开了使用针对所述蛋白质的抗体进行被动免疫和诊断。
    • 3. 发明授权
    • Method for selecting and producing vaccine components and vaccines based thereon
    • 基于此选择和制备疫苗组分和疫苗的方法
    • US08142789B2
    • 2012-03-27
    • US10556733
    • 2004-05-17
    • Cornelis Johannes LeenhoutsRonald de GrootPeter Wilhelmus Maria Hermans
    • Cornelis Johannes LeenhoutsRonald de GrootPeter Wilhelmus Maria Hermans
    • A61K39/02
    • A61K39/092A61K2039/505C07K16/1275G01N33/56911Y02A50/47
    • The invention relates to the field of biology, more specifically to the field of immunology and microbiology. The invention further relates to the field of vaccines against microbial infections and especially bacterial vaccines, in particular to pneumococcal vaccines. More in particular, the invention relates to means and methods to identify, select and isolate a vaccine component for passive and/or active immunisation against a microorganism that can be killed by opsonophagocytic cells. The invention relates to a method to identify an opsonophagocytosis inducing antigen as a vaccine component for immunisation against a microorganism. The invention describes three pneumococcal proteins SlrA, IgAl proteinase, and PsaA, and their use as a vaccine component with or without PpmA. The invention also discloses the use of antibodies against said proteins for passive immunization and diagnosis.
    • 本发明涉及生物学领域,更具体涉及免疫学和微生物学领域。 本发明还涉及针对微生物感染的疫苗领域,特别是细菌疫苗领域,特别是肺炎球菌疫苗领域。 更具体地,本发明涉及鉴定,选择和分离针对可被调理吞噬细胞杀死的微生物的被动和/或主动免疫的疫苗组分的方法和方法。 本发明涉及一种鉴定诱导免疫细胞因子的抗原作为免疫微生物的疫苗组分的方法。 本发明描述了三种肺炎球菌蛋白SlrA,IgA1蛋白酶和PsaA,以及它们作为具有或不具有PpmA的疫苗组分的用途。 本发明还公开了使用针对所述蛋白质的抗体进行被动免疫和诊断。